Healthcare & Life Sciences
Affinivax
United Statesaffinivax.com
Affinivax is a series c plus startup based in United States. 1 investor tracked. Status: acquired.
Acquiredacquired
acquired
Stage
2014
Founded
3
Investors
About Affinivax
Based in the United States, Affinivax is a startup founded in 2014. Affinivax has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Affinivax is a clinical-stage biotechnology company developing next-generation pneumococcal vaccines using its novel Multiple Antigen Presenting System (MAPS) technology to provide broader and potentially more effective protection against infectious diseases.
Explore Affinivax's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.